* LifeMD Inc LFMD.OQ LFMD.O is expected to show a rise
in
quarterly revenue when it reports results on May 12.
* The New York City-based company is expected to report a
6.0% increase in revenue to $30.8 million from $29.04 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. The company's guidance on March 22 2023, for the
period ended March 31, was for revenue between $31.00 million
and $32.00 million.
* Refinitiv's mean analyst estimate for LifeMD Inc is for a
loss
of 16 cents per share.
* The one available analyst rating on the shares is "strong
buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LifeMD Inc
is
$7, above its last closing price of $1.69.
The company's guidance on March 22 2023 for the period ended
March 31 was for Earnings before Interest, Taxes, Depreciation
and Amortization of between USD31 million and USD1.5 million.
This summary was machine generated May 10 at 12:38 GMT. All
figures in US dollars unless otherwise stated